Research: 3 Employee Experiences Most Likely to Drive Retention
January 30, 2024 07:00 ET
|
Great Place To Work
Oakland, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- What experiences predict whether your employees are going to quit or stay? New data from Great Place To Work® reveals three experiences that are...
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
January 30, 2024 07:00 ET
|
OTC Markets
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the fourth quarter...
TRU Staffing Partners Unveils Comprehensive 2024 eDiscovery Jobs Report at LegalWeek 2024
January 30, 2024 07:00 ET
|
TRU Staffing Partners
TRU Staffing Partners today announced the release today announced the release of its highly anticipated 2024 eDiscovery Jobs Report during ALM’s LegalWeek.
LOVE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Lovesac Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
January 30, 2024 07:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Preqin announces new Head of Benchmarks and Head of Research Insights
January 30, 2024 07:00 ET
|
Preqin Ltd
LONDON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Preqin, the global leader in alternative assets data, tools, and insights, announced the appointment of key senior leaders to accelerate key products and...
ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
January 30, 2024 07:00 ET
|
ITM Isotope Technologies Munich SE
GARCHING / MUNICH, Germany and VANCOUVER, British Columbia, January 30, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9),...
RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
January 30, 2024 06:58 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...
Global Feed Palatability Enhancers Market Forecast, 2018-2028 - CAGR of 3.13%, Focused on Innovation and Sustainability
January 30, 2024 06:57 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Feed Palatability Enhancers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
YESCARTA (Axicabtagene Ciloleucel) Drug & Market Analysis 2023-2032: Pipeline Developments, Clinical Advancements, SWOT Analysis, and Emerging Therapies for Treating DLBCL
January 30, 2024 06:53 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "YESCARTA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This in-depth analysis of YESCARTA...
Global Chondroitin Sulfate Market Forecast Report 2018-2028 - Opportunities in Pharmaceutical and Cosmetic Industries Through 2028
January 30, 2024 06:51 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Chondroitin Sulfate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
- April 19, 2024 13:13 ET The Boston Beer Company Debuts First-of-its-Kind Non-Alc Beverage, General Admission, Available Now via Direct-to-Consumer Shipping
- April 19, 2024 13:00 ET Endowment fund helps undergraduates explore career opportunities